Document is current
Any future updates will be listed below
-
Authors
Jian, Ching https://orcid.org/0000-0003-0577-8834
Silvestre, Marta Paulino
Middleton, Danielle
Korpela, Katri
Jalo, Elli
Broderick, David
de Vos, Willem Meindert
Fogelholm, Mikael
Taylor, Mike William
Raben, Anne
Poppitt, Sally
Salonen, Anne https://orcid.org/0000-0002-6960-7447
-
Funding
Funding for this research was provided by:
EU 7th Framework Programme (# 312057)
New Zealand Health Research Council (grant #14/191)
University of Auckland Faculty Research Development Fund (grants #3702182, #3706738)
Helsingin Yliopisto
Mary and Georg Ehnrooth Foundation
Otto A. Malm Lahjoitusrahasto
- License Information
-
More Information
Article History
Received: 23 March 2022
Accepted: 4 May 2022
First Online: 23 May 2022
Declarations
:
: The work of PREVIEW is carried out in full compliance with the relevant requirements of the latest version of the Declaration of Helsinki (59th WMA General Assembly, Seoul, Korea, October 2008), and the ICH-GCP, The International Conference on Harmonisation (ICH) for Good Clinical Practice to the extent that this is possible and relevant. The study protocol was approved by the Ethical Committees of participating countries (Health and Disability Ethics Committee in New Zealand, ref. 14/191 and Medical Ethical Committees of the Hospital District of Helsinki and Uusimaa and HUCH in Finland, ref. 171/13/03/00/2013). All participants provided written informed consent prior to commencing screening procedures in clinic. All information obtained during the trial is handled according to local regulations and the European Directive 95/46/CE (directive on protection of individuals with regard to the processing of personal data and on the free movement of such data). The PREVIEW trial was prospectively registered at ClinicalTrials.gov (NCT01777893) on January 29, 2013.
: Not applicable.
: The authors declare that they have no competing interests.
